Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8863482 | 0.86 | — | — | |
| SCHEMBL19156749 | 0.85 | SLC18A3 (0.35) | — | |
| SCHEMBL22023850 | 0.85 | — | — | |
| SCHEMBL17643565 | 0.79 | — | — | |
| SCHEMBL18900942 | 0.79 | — | — | |
| SCHEMBL16349212 | 0.79 | — | — | |
| SCHEMBL30155 | 0.79 | LMNA (0.32) | GBA1 | |
| SCHEMBL14473283 | 0.79 | CYP2C9 (0.32) | GBA1 | |
| SCHEMBL13900980 | 0.79 | CYP2C9 (0.32) | GBA1 | |
| SCHEMBL14640205 | 0.79 | LMNA (0.32) | GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183571-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-06-15 | — | — | US | disclosed |
| US-20230183571-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-06-15 | — | — | US | disclosed |
| US-11667845-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| US-11667845-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| US-20170362506-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-12-21 | — | — | US | disclosed |
| US-20170362506-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-12-21 | — | — | US | disclosed |
| EP-3228681-A1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | Merck Patent GmbH (DE) | 2017-10-11 | — | — | EP | disclosed |
| WO-2017162707-A1 | CYANOPYRIMIDINE DERIVATIVES SUITABLE AS COMPONENTS IN LIQUID CRYSTAL MEDIA | MERCK PATENT GMBH (DE) | 2017-09-28 | — | — | WO | disclosed |
| WO-2017162717-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-09-28 | — | — | WO | disclosed |
| WO-2017162716-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-09-28 | — | — | WO | disclosed |
| WO-2007017008-A1 | ELECTRO-OPTICAL LIGHT MODULATION ELEMENT, DISPLAY AND MEDIUM | MERCK PATENT GMBH (DE) | 2007-02-15 | — | — | WO | disclosed |
| WO-2007017180-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2007-02-15 | — | — | WO | disclosed |
| EP-1752510-A1 | Liquid crystalline medium | Merck Patent GmbH (DE) | 2007-02-14 | — | — | EP | disclosed |
| EP-1431369-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2007-01-31 | — | — | EP | disclosed |
| WO-2007009636-A1 | S-INDACENE AND INDENO[5,6-D][1,3]DIOXOL-DERIVATIVES AND USE THEREOF AS COMPONENTS OF LIQUID-CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2007-01-25 | — | — | WO | disclosed |
| EP-1746079-A2 | Fluorinated biphenyl compounds for use in liquid crystal compositions | Merck Patent GmbH (DE) | 2007-01-24 | — | — | EP | disclosed |
| US-20070001149-A1 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-1310474-B1 | Fluorinated biphenyl compounds and their use in liquid crystal compositions | MERCK PATENT GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
| EP-1365001-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
| EP-1561150-B1 | ELECTROOPTICAL LIGHT MODULATING ELEMENT, ELECTROOPTICAL DISPLAY AND MODULATING MEDIUM | MERCK PATENT GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667845-B2 | Liquid crystalline medium | NEFM, CCNI, MYT1 | GBA1 2836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.